BSE FMCG Sector Regulatory Filings — August 08, 2026

Prestige & Above volume grew at 21% CAGR (FY2021-26), reaching 38.3M cases and 45.6% of total IMFL volume, with value share at 70.3%

Realisation per case for Prestige & Above improved from ₹1,510 in FY2021 to ₹1,834 in FY2026 (₹324/case or +21.5% upside); total realisation also rose from ₹1,180 to ₹1,717 ( +45.5% )

FY2026 net revenue of ₹6,050 Cr and EBITDA margin of 16.8%, with IMFL volume growth of 22% YoY – outperforming the industry's 3.5% long-term volume CAGR

Supply-chain optimisation led to 300 bps gross margin improvement in Q1 FY2027 over the previous year, validating operating leverage benefits

Regular segment volume declined 12% YoY (Q1 FY2027) even as premium grew 24%, confirming the mix shift but signaling pressure in the value end

Industry volume growth for spirits is projected at a modest 3.5% CAGR (2025-30), which could constrain total addressable market expansion and keep a lid on volumetric momentum

No disclosures of insider buying or selling in the filing period – reduced transparency on management conviction around the premiumisation story [NEUTRAL/BEARISH]

Inventory days remained elevated at 85 days (vs FMCG average of 55-65 days), indicating working capital drag despite revenue growth

Regular segment volume fell 12% YoY in Q1 FY2027; if consumer down-trading accelerates (due to inflation or rural stress), the product mix shift could stall, pressuring overall volumes and capacity utilisation

The industry's 3.5% volume CAGR (2025-30) is well below FMCG staples averages; any slower-than-expected premium adoption could lead to revenue growth falling below 8-10% CAGR, disappointing growth expectations

16.8% margin (FY2026) is higher than historical levels but still lower than some high-premium peers (e.g., United Spirits 18-20%); margin expansion beyond 18% requires further shifts to Prestige & Above, which becomes harder as premium base grows

At ~₹6,050 Cr revenue with premiumisation compressing to lower YoY gains, any slowdown in realisation growth could pressure the elevated valuation multiples (trading at ~35-40x P/E based on market data)

Excise policy changes in key states (Uttar Pradesh, Maharashtra, Karnataka) remain a recurring risk; any increase in the taxation or regulatory compliance burden could compress margins by 100-200 bps

The filing lacks any reference to dividends, buybacks, or capex plans; this absence suggests management may be conserving cash for debt repayment or inorganic moves, adding uncertainty to total shareholder returns

Inventory at 85 days tied to premium SKU build-up could lead to higher obsolescence costs if demand softens; this is a hidden risk in an otherwise bullish premiumisation narrative

Prestige & Above segment has achieved 21% CAGR over 5 years – if it maintains even 15% growth, total revenue can cross ₹7,500 Cr by FY2028, providing a 24% upside potential from FY2026 base

With Prestige & Above price realisation at ₹1,834/case vs regular at ~₹1,200/case, shifting just 5% of regular volume to premium could boost EBITDA by ₹60-80 Cr annually (1.0-1.3% margin expansion)

300 bps YoY improvement in Q1 FY2027 gross margin suggests operating leverage is kicking in; if sustained, full-year EBITDA margin could exceed 17.5%, beating current guidance

Indian per capita alcohol consumption remains low vs global peers; expansion in smaller towns via their vast distribution (over 50,000 outlets) can drive 5-7% volume tailwinds for premium brands

The launch of lower-ABV premium products and flavoured whiskies positions Radico to capture a rising consumer preference for premium IMFL (market growing at 8-10% in value), with limited competition from global players

While no insider buying was reported, there was also no insider selling in the current filing period, suggesting management is not unwinding positions despite elevated stock – could signal confidence in the premiumisation roadmap [WATCH/OPPORTUNITY]

No M&A disclosed, but the company has historically used inorganic moves to gain premium brands; a potential mid-sized acquisition (e.g. regional craft distillery) could accelerate premiumisation faster than organic growth

70.3% of IMFL value from Prestige & Above provides a buffer against volume shocks; even if total volume drops 5%, revenue may only decline 1-2% due to the premium mix – a defensive quality in downturns

Radico Khaitan’s strong mix shift (Prestige & Above 70.3% value share) mirrors a broader FMCG trend of trading up. However, unlike packaged foods or home care, alcohol faces a lower-volume universe (industry 3.5% CAGR), making mix the only growth lever; a bet on premiumisation is a bet on sustained consumer upgrading in a macro-tight environment

The sharp contrast between 24% premium volume growth and 12% regular decline at Radico Khaitan highlights a sector-wide bifurcation: premium/affordable-luxury categories are outperforming while mass-market staples stagnate. FMCG investors should watch for similar divergence in other sub-segments like soaps, biscuits, and beverages

With no dividends, buybacks, or capex discussed in the Radico filing, there is a pattern of selective disclosure in the sector. Investors may need to triangulate capital allocation from quarterly calls rather than investor presentations; this reduces transparency and raises the need for engagement during earnings season

The lack of insider trading data in Radico’s presentation (even though it is a voluntary filing) suggests that many FMCG companies may not be using investor presentations to convey management confidence. Investors should cross-check with NSE bulk-deal data and BSE insider filings for signals

Inventory at 85 days reflects a structural shift: premium SKUs require longer ageing (especially for spirits) and broader distribution investment. Across FMCG, companies aggressively pushing premiumisation may show higher inventory days (20-30% above historical average), masking cash flow generation. This is a cross-sector risk for cash-flow-focused investors

Scheduled for early November 2026; watch for any revision to the 16.8% EBITDA margin guidance, especially if Q1 gross margin improvement (300 bps) is sustained. A margin beat above 17% could trigger re-rating

The ongoing 12% YoY decline in regular volume needs monitoring. If the regular segment stabilises (indicating no further consumer down-trading), it would remove a key risk; if it worsens, it could cap volume growth below 7%

Realisation per case increased from ₹1,510 to ₹1,834 over 5 years (₹324). If Q1 FY2027 trends show a further uptick above ₹1,900/case, premiumisation is accelerating faster than expected, justifying higher multiples

These two states account for roughly 35% of IMFL sales; any state budget announcements in September/October 2026 that raise excise duties could compress margins by 100-150 bps

No insider activity was reported in the investor presentation. Investors should monitor BSE’s insider filing database for any post-presentation purchases by the promoter or CFO, which would signal strong conviction

The IWSR/DISCUS estimate of 3.5% CAGR for spirits (2025-30) is a top-down input. Any upward revision (e.g. to 4.5-5%) would substantially improve Radico’s addressable market and growth runway

The company has no current M&A disclosure, but the investor presentation highlights the need for premium brand additions. Any deal – especially acquiring a niche premium brand – could provide a near-term catalyst